Medical Health & Life Science Research News

2021 projections puts varicose vein treatment market in North America at $ 138.04 million according to new research report

This report provides information about Research Methodology, Drivers, Restraints, Opportunities, and Challenges Analysis , market Segmentation ,Geographical Analysis ,Strategic Analysis & Market Leaders of Varicose Vein Treatment Market in North America

- Advertising -

The North America Varicose Vein Treatment Market was worth USD 101.7 million in 2016 and estimated to be growing at a CAGR of 6.3%, to reach USD 138.04 million by 2021.

Report: www.orbisresearch.com/contacts/request-sample/391883

The varicose vein treatment market is growing due to the increased prevalence of varicose veins. This condition of enlarged veins appears mostly in feet and legs.

It can be caused by pregnancy, hormonal changes, genetic disorders and high blood pressure.

- Advertising -

The market for varicose vein treatment is fuelled by factors such as reduced trauma, greater exposure to the site of application, high operative success rates, and faster blood flow restoration, improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population. Factors such as the high cost of varicose vein treatment procedures, lack of training for vascular surgeons, implementation of health care reforms, immensely competitive market leading to difficulty in maintaining sustainability, and inconsistent reimbursement scenario pose a threat to the development of the varicose vein treatment market.

The major players in the varicose vein treatment market are Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd.

(Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc.

(U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.) .

This report broadly segments the varicose vein treatment market into mode of treatment and products. On the basis of mode of treatment, the varicose vein treatment market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping.

The endovenous ablation segment is expected to command the major share of the varicose vein treatment market, by mode of treatment. Based on type of products, the varicose vein treatment market is segmented into ablation devices, venous closure products, and surgical products.

The radiofrequency ablation devices segment is expected to command the major share of the ablation devices market for varicose vein treatment. On the basis of geography, the market is analysed under various regions- U.S.A and Canada.

North America is dominating the global market.

Report Details at www.orbisresearch.com/reports/inde…recasts-2016-2021

The major players in the varicose vein treatment market are Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd.

(Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc.

(U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.)

 

News From

Orbis Research - Rendering Conscientious ResearchOrbis Research
Category: Market Research Publishers and RetailersCompany profile: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have a vast database of reports from the leading publishers and authors across the gl obe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their need, and we produce the perfect requi ...